To overcome this limitation, we performed parallel in vivo and in vitro CRISPR/Cas9 functional screens to investigate targetable dependencies of GSCs and identified RBBP6 as a consistent regulator of GSC maintenance and tumor formation in vitro and in vivo. This evidence concerns the gene RBBP6 and neoplasm.